Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Mol Genet Metab. 2013 Apr 6;109(2):139–143. doi: 10.1016/j.ymgme.2013.03.019

Table 1.

Patient characteristics.

Patient # Gender Diagnosis DCA Exposure (years) Current Age (years) GSTZ1 Haplotype
Patient 1 F PDC Deficiency 14.8 20.3 EGT/EGT
Patient 2 F PDC Deficiency 14.8 20.3 EGT/EGT
Patient 3 F PDC Deficiency 13.5 16.7 EGT/KGT
Patient 4 F Complex I 11.9 23.7 EGT/KGT
Patient 5 M Complex I & V 12.5 20.7 KGT/KGT
Patient 6 M Complex IV 10.8 18.7 nd
Patient 7 M Complex IV 10.8 16.8 nd
Patient 8 M mtDNA T9997C 10.0 49.6 EGT/EGT
Mean: 12.4
Total patient yrs: 99.1

nd, not determined. These patients were lost to follow-up before genotyping could be performed.